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Butwicka and colleagues1 have published a fascinating, landmark cohort study in 
this issue of JAMA Pediatrics assessing the prevalence of psychiatric diagnoses and 
symptoms among children with inflammatory bowel disease (IBD) in Sweden. The 
authors used a rigorous design that compared a cohort of more than 6000 pediatric 
patients with IBD with hundreds of thousands of healthy controls, as well as a separate 
cohort comprising the patients’ own siblings who did not have IBD. Butwicka et al1 
computed hazard ratios for any psychiatric disorder, as well as for multiple specific 
disorders, and found a hazard ratio of 1.6 for any psychiatric diagnosis when comparing 
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children with IBD with healthy controls. The statistical analysis is stellar and represents 
the best data we currently have on the intersection of pediatric IBD and mental health. 
Their study highlights a substantial risk in a vulnerable population and should trigger 
revision of guidelines and allocation of resources to support widespread screening and 
treatment for these dangerous conditions. 
The authors’ use of a comparison group of siblings that eliminates confounders 
present within families makes their findings particularly impactful. Because mental health 
diagnoses cluster within families and have strong social determinants, isolating a 
particular diagnosis such as IBD as the likely causative factor for a psychiatric disorder 
requires careful research design. The authors should be applauded for this effort, and we 
are very excited to see such rigorous study of this important problem. 
An alternative explanation for their findings is that patients with a chronic illness 
such as IBD are more likely to receive a diagnosis, but they are not necessarily more 
likely to have the disorder. The authors used a single assignment of a psychiatric 
International Classification of Diseases code to define the presence of mental illness. Low 
sensitivity and specificity of International Classification of Diseases codes is the rule, and 
both have been found to be lower than 80% in psychiatric codes present in populations 
with other chronic diseases.2 Some of this phenomenon is probably explained by the 
concept of “diagnosis creep,” where having 1 diagnosis of a chronic illness often results 
in the assignment of more diagnoses by physicians, irrespective of diagnostic validity.3 
Unfortunately, to resolve this issue definitively would require a very large study 
with formal mental health screening (confirmed by a mental health practitioner) in a 
 
 
prospective pediatric cohort of patients with IBD, as well as matched healthy controls and 
siblings. This would be an enormous undertaking, and the magnitude of the findings by 
Butwicka et al1 make their results highly likely to represent reality. 
In addition, the authors do not distinguish between mild and severe psychiatric 
disorders, as it is not possible based on their data source and study design. Mild 
depression, for instance, has a very high prevalence in adolescence,4 as much as 33%, 
and may not be associated with IBD care, overall morbidity, or risk of death nearly as 
much as severe cases of depression, where suicidal ideation is much more common. 
Finally, this study takes place in a single country with a single population that is largely 
genetically and culturally homogeneous, and in a system with high levels of health care 
access and a nationalized health care system. Although there is no reason to think that 
the correlation would not be present in other settings based on this finding alone, the IBD 
research community should continue to assess this phenomenon in other health care 
systems and populations. 
Perhaps even more relevant to pediatric gastroenterologists and pediatricians, the 
study by Butwicka et al1 found that the association between IBD and psychiatric 
diagnoses was stronger during childhood (a hazard ratio of 2.1 until 18 years of age 
compared with a hazard ratio of 1.6 during the entire study period, which extended into 
early adulthood for most individuals). Their findings thus strongly indicate a need for more 
focused intervention during adolescence, when patients appear to be even more 
vulnerable. Because suicide is the third leading cause of death in teenagers, and 
depression is the leading cause of morbidity,5 careful attention to these disorders in 
 
 
patients with IBD is paramount. An integrated mental health and digestive health model 
is the simplest, and best, solution. 
There are numerous screening strategies for the equally numerous comorbidities 
in IBD that have become standard of care, with even lower hazard ratios than described 
in the study by Butwicka et al1: tuberculosis screening in patients taking tumor necrosis 
factor inhibitors,6 screening for vitamin D deficiency and dual-energy x-ray absorptiometry 
scans in children with Crohn disease,7 and iron deficiency screening,8 among many 
others. Overall, we have found the barriers to accomplishing such screening to be quite 
low and the cost is usually covered by payors. So, one would be hard pressed to find a 
patient taking a tumor necrosis factor inhibitor who did not undergo a screening test for 
tuberculosis, but it is doubtful that formal screening for depression and anxiety have been 
performed on these same patients, despite the fact that, especially in a region with a low 
prevalence of tuberculosis, patients are at much higher risk of suicide than they are of 
latent infection reactivated by a tumor necrosis factor inhibitor. 
There is a strong precedent for integrating ancillary health services into IBD care. 
Presently, many pediatric IBD centers have integrated nutrition support, which clearly 
improves outcomes in patients at high risk for consequences of malnutrition.9 In addition, 
most centers have social work and care coordination as well, which are also clearly linked 
to improved clinical outcomes across many chronic conditions.10 However, as Butwicka 
et al1 clearly demonstrate in the present study, the risk for psychiatric disorders remains 
high, but the infrastructure we have in place to deal with these problems is utterly 
inadequate. Integrated mental health care has been shown to be highly effective at 
 
 
reducing the burden of mental health disease in primary care settings,11 but there has not 
been widespread adoption of this strategy either in primary care or pediatric subspecialty 
care, despite evidence for efficacy. 
Inadequate integration is only a part of the systemic problem, though, because 
limited access to mental health services is endemic both in North America and elsewhere. 
There exists consistently inadequate access to mental health services in the general 
pediatric population12 as well as in specific vulnerable pediatric populations, including 
patients with IBD,13 those receiving public financial services,14 and racial/ethnic 
minorities.15 So one aspect of solving the high rate of psychiatric disorders in pediatric 
patients with IBD is improving access to mental health broadly across the health care 
system. 
We suggest that regular screening for mental health disorders, especially 
depression and suicidal ideation, be instituted immediately in all children with IBD. 
Screening can be accomplished quickly, with minimal cost and disruption of clinic 
workflow.16 We have just completed a single-center comparative effectiveness study 
supported by the Agency for Healthcare Research and Quality and National Institutes of 
Health called the DECADES (Detecting and Evaluating Childhood Depression Effectively 
in Subspecialties) trial, which randomizes children who have positive screening results 
for anxiety or depression to receive either usual care or an immediate integrated mental 
health care visit after their gastroenterology visit. Our preliminary findings support the 
work of Butwicka et al,1 with a high rate of positive screening results and higher quality of 
life scores for those who receive integrated mental health care services. As a result, we 
 
 
have begun instituting more rigorous screening for anxiety and depression in our patients 
across multiple sites. 
Mental health disorders are perhaps the greatest threat to life and happiness that 
young people face, especially those with chronic illness. Butwicka et al1 clearly show that 
childhood-onset IBD represents a particularly strong risk factor for mental health 
disorders. We therefore urge physicians and other stakeholders to institute mental health 
screening procedures and adequate integrated mental health care for children with IBD 
immediately and allocate resources to reduce this serious risk to life and health. 
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